Ali Erginay · enciclopedia

Publicaciones › Edema macular diabético y sus tratamientos

Hypoglycaemia is associated with the absence of a decrease in diurnal macular thickness in patients with diabetic macular oedema

La hipoglucemia se asocia con la ausencia de disminución en el grosor macular diurno en pacientes con edema macular diabético

Año2013
FuenteDiabetes & metabolism
Tipoarticle · Journal Article, Research Support, Non-U.S. Gov't
Autores (7)S Feldman-Billard, B Dupas, N Sedira, J Bitu, A Erginay, P J Guillausseau, P Massin
Posición de Erginay5 de 7
Citas6 (OpenAlex)
EnlacesDOI 10.1016/j.diabet.2012.12.001 · PubMed 23337517 · OpenAlex
LíneasEdema macular diabético y sus tratamientos Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo

En pocas palabras

Se estudió cómo cambia el grosor de la mácula a lo largo del día en pacientes con edema macular diabético. Los investigadores encontraron que los pacientes que experimentaron episodios de hipoglucemia no tenían la disminución habitual en el grosor macular durante el día. Esto sugiere que la hipoglucemia podría influir en los cambios diurnos del grosor macular en estos pacientes.

Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.

Resumen original

Spontaneous diurnal variations measured by optical coherence tomography (OCT) have been reported in diabetic macular oedema (DME) together with a daytime decrease in central macular thickness (CMT). For this reason, this study aimed to investigate the influence of acute glucose and blood pressure changes on daytime variations in CMT in patients with DME. In this prospective observational study of type 1 (n=4) and type 2 (n=18) diabetic patients with DME, OCT scans, capillary blood glucose, and systolic and diastolic blood pressure measurements were performed at 9 a.m., 12 a.m., 3 p.m., 6 p.m. and again at 9 a.m. the day after. At the same time, the study protocol included simultaneous ambulatory blood pressure and glucose monitoring over a 24-h period. Hypoglycaemic episodes, defined as glucose values<60mg/dL, were also recorded. CMT decreased consistently between 9 a.m. and 6 p.m. in 10 patients (from 374±82μm to 337±72μm; P=0.01) and increased or remained steady in 12 others (from 383±136μm to 390±149μm; P=0.58), with a significant difference in CMT absolute change between the two groups (P<0.001). In the study population as a whole, the lower the mean diurnal blood glucose, the smaller the decrease in CMT during the day (P=0.027). Also, eight (67%) of the 12 patients with a flat CMT profile experienced a diurnal hypoglycaemic event whereas none of those with a CMT decrease had hypoglycaemia (P=0.002). Hypoglycaemic events may explain the lack of diurnal CMT decrease in diabetic patients with DME. However, further studies need to be conducted to evaluate whether having no diurnal CMT decrease is associated with a poorer visual prognosis and whether it can be modified by better glucose control.

Términos MeSH

Adolescent Adult Aged Blood Glucose Blood Pressure Blood Pressure Monitoring, Ambulatory Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetic Retinopathy Female Follow-Up Studies France Glycated Hemoglobin Humans Hypoglycemia Macular Edema Male Middle Aged Prospective Studies Retina Tomography, Optical Coherence Vascular Endothelial Growth Factor A